Region: North America

Enforcement-related considerations for patent valuation: the perspective from Canada

The valuation of patent rights is not a straightforward matter. In Canada, the remedies available to patent owners are arguably the most important factor in determining value.

12 January 2022

Alibaba, Panasonic among first to join Access Advance VVC patent pool

Twenty-eight patent owners announced as charter participants in licensing platform launched last July

12 January 2022

New wave of fitness-related patent litigation driven by booming market and brand concerns

Recent lawsuits involving Nike, Peloton, lululemon and others suggest an explosion in consumer demand for high-tech workout gear is leading to IP conflict

11 January 2022

Why the Illinois Northern District has become a hotbed of design patent injunctions

Lead counsel representing brands Oakley and Ugg explains how design rights help companies pursue copycats that have gotten savvier about trademark use

10 January 2022

AbbVie heads to the ITC in dramatic final battle over Humira biosimilars

Chicago-based company seeking to exclude Alvotech’s adalimumab product from the US market for alleged trade secret misappropriation

10 January 2022

Q3 2021 saw a software surge in US patent sales

The most recent AST data shows a 12-point jump in transacted assets, as well as continuing strength in healthcare and semiconductors

07 January 2022

IPCom patent campaign against Apple in China appears to end with global settlement

Report suggests German NPE walked away from long-running dispute with eight-digit sum, ending litigation in Fuzhou

07 January 2022

Vidal USPTO Director confirmation vote cancelled, but not due to opposition to her appointment

The Senate Judiciary Committee is all set to endorse her appointment but has been delayed in doing thanks to a funeral and a riot’s anniversary

06 January 2022

Open RAN patent pool raises eyebrows, but operators promise balance

Critics suggest Alium will favour implementers by offering royalty rates that are inadequate for licensors

05 January 2022

How looming patent cliffs are impacting pharma IP strategies

Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.

05 January 2022

Get unlimited access to all IAM content